Method for Prediction of Efficacy of Genetic-Based Prediction Models of Personali View Homepage


Ontology type: schema:MonetaryGrant     


Grant Info

YEARS

2009-2011

FUNDING AMOUNT

966964 USD

ABSTRACT

DESCRIPTION (provided by applicant): The collection of newly discovered clinically valuable genetic tests is far outpacing our ability to use clinical trials to determine their clinical efficacy and determine which of the collection of tests and associated algorithms are best suited for any given clinical setting. For example, a review of the literature demonstrates that at least 35 published algorithms for the prediction of therapeutic warfarin dosing have been published in the past ten years, nine of which include genotype data (unpublished review). Expenditures to determine the most clinical useful of these algorithms include a total of 19 clinical trials (clinicaltrials.gov, accessed Feb, 2008) Compounding this complexity and adding to the delay of the successful medical use of the rapidly expanding collection of clinically valuable genetic discoveries is the lack of clinical and biomedical informatic methods, tools and infrastructure required to facilitate the successful translation of the discoveries to practical clinical use. Efforts to translate important biomedical informatics methods, tools and processes required to implement important new genetic discoveries in the clinical setting are severely hindered by regulatory, technical and validation barriers not easily resolved in the current clinical-research or clinical enterprise environments. This proposal will test an environment and methodology that creates clinical avatars with data statistically consistent with actual patient electronic medical records. Once created, these clinical avatar medical records will be used to conduct insilico experiments to compare genetic- based algorithms and their predicted value in the clinical setting. We will develop and test the methodology and create the applications by conducting a series of clinical avatar simulations and subsequent analysis of genetic-based warfarin dosing prediction. Once developed, we will conduct a series of insilico clinical trials comparing various clinical and genetic factors to demonstrate the efficacy of the warfarin dosing algorithms. This work is representative of similar projects that may be designed to test other personalized medicine devices such as genetic tests used to quantify risk to cancers, pharmacogenetic problems, and other FDA labeled "IVDMIA" devices (e.g. Genetic Health's Oncotype DX(R)) projected to improve predictive and preventive personalized medicine. More... »

URL

http://projectreporter.nih.gov/project_info_description.cfm?aid=7828231

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2208", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "amount": {
      "currency": "USD", 
      "type": "MonetaryAmount", 
      "value": "966964"
    }, 
    "description": "DESCRIPTION (provided by applicant): The collection of newly discovered clinically valuable genetic tests is far outpacing our ability to use clinical trials to determine their clinical efficacy and determine which of the collection of tests and associated algorithms are best suited for any given clinical setting. For example, a review of the literature demonstrates that at least 35 published algorithms for the prediction of therapeutic warfarin dosing have been published in the past ten years, nine of which include genotype data (unpublished review). Expenditures to determine the most clinical useful of these algorithms include a total of 19 clinical trials (clinicaltrials.gov, accessed Feb, 2008) Compounding this complexity and adding to the delay of the successful medical use of the rapidly expanding collection of clinically valuable genetic discoveries is the lack of clinical and biomedical informatic methods, tools and infrastructure required to facilitate the successful translation of the discoveries to practical clinical use. Efforts to translate important biomedical informatics methods, tools and processes required to implement important new genetic discoveries in the clinical setting are severely hindered by regulatory, technical and validation barriers not easily resolved in the current clinical-research or clinical enterprise environments. This proposal will test an environment and methodology that creates clinical avatars with data statistically consistent with actual patient electronic medical records. Once created, these clinical avatar medical records will be used to conduct insilico experiments to compare genetic- based algorithms and their predicted value in the clinical setting. We will develop and test the methodology and create the applications by conducting a series of clinical avatar simulations and subsequent analysis of genetic-based warfarin dosing prediction. Once developed, we will conduct a series of insilico clinical trials comparing various clinical and genetic factors to demonstrate the efficacy of the warfarin dosing algorithms. This work is representative of similar projects that may be designed to test other personalized medicine devices such as genetic tests used to quantify risk to cancers, pharmacogenetic problems, and other FDA labeled \"IVDMIA\" devices (e.g. Genetic Health's Oncotype DX(R)) projected to improve predictive and preventive personalized medicine.", 
    "endDate": "2011-12-30T00:00:00Z", 
    "funder": {
      "id": "https://www.grid.ac/institutes/grid.280285.5", 
      "type": "Organization"
    }, 
    "id": "sg:grant.2545608", 
    "identifier": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "2545608"
        ]
      }, 
      {
        "name": "nih_id", 
        "type": "PropertyValue", 
        "value": [
          "R01LM010130"
        ]
      }
    ], 
    "inLanguage": [
      "en"
    ], 
    "keywords": [
      "clinical trials", 
      "literature", 
      "other FDA", 
      "clinical setting", 
      "infrastructure", 
      "insilico clinical trials", 
      "discovery", 
      "genotype data", 
      "IVDMIA", 
      "device", 
      "valuable genetic discoveries", 
      "expenditure", 
      "clinical efficacy", 
      "successful translation", 
      "risk", 
      "data", 
      "genetic-", 
      "efforts", 
      "genetics", 
      "METHODS", 
      "warfarin dosing algorithms", 
      "similar projects", 
      "unpublished reviews", 
      "preventive personalized medicine", 
      "actual patient electronic medical records", 
      "test", 
      "values", 
      "genetic factors", 
      "tool", 
      "process", 
      "other personalized medicine devices", 
      "representative", 
      "Genetic Health's Oncotype DX(R", 
      "example", 
      "prediction", 
      "ability", 
      "efficacy", 
      "Prediction Models", 
      "algorithms", 
      "applicants", 
      "review", 
      "genetic-based warfarin", 
      "successful medical use", 
      "years", 
      "collection", 
      "algorithm", 
      "clinical avatar simulations", 
      "description", 
      "clinical avatar", 
      "insilico experiments", 
      "application", 
      "medical records", 
      "genetic tests", 
      "given clinical setting", 
      "delay", 
      "subsequent analysis", 
      "cancer", 
      "work", 
      "biomedical informatics methods", 
      "Personali", 
      "FeB", 
      "environment", 
      "series", 
      "clinical enterprise environments", 
      "practical clinical use", 
      "validation barriers", 
      "complexity", 
      "total", 
      "important new genetic discoveries", 
      "proposal", 
      "lack", 
      "valuable genetic tests", 
      "methodology", 
      "therapeutic warfarin", 
      "important biomedical informatics methods", 
      "pharmacogenetic problems"
    ], 
    "name": "Method for Prediction of Efficacy of Genetic-Based Prediction Models of Personali", 
    "recipient": [
      {
        "id": "https://www.grid.ac/institutes/grid.38142.3c", 
        "type": "Organization"
      }, 
      {
        "affiliation": {
          "id": "https://www.grid.ac/institutes/grid.38142.3c", 
          "name": "HARVARD MEDICAL SCHOOL", 
          "type": "Organization"
        }, 
        "familyName": "TONELLATO", 
        "givenName": "PETER J.", 
        "id": "sg:person.01052034706.31", 
        "type": "Person"
      }, 
      {
        "member": "sg:person.01052034706.31", 
        "roleName": "PI", 
        "type": "Role"
      }
    ], 
    "sameAs": [
      "https://app.dimensions.ai/details/grant/grant.2545608"
    ], 
    "sdDataset": "grants", 
    "sdDatePublished": "2019-03-07T11:59", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com.uberresearch.data.processor/core_data/20181219_192338/projects/base/nih_projects_11.xml.gz", 
    "startDate": "2009-07-01T00:00:00Z", 
    "type": "MonetaryGrant", 
    "url": "http://projectreporter.nih.gov/project_info_description.cfm?aid=7828231"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/grant.2545608'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/grant.2545608'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/grant.2545608'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/grant.2545608'


 

This table displays all metadata directly associated to this object as RDF triples.

120 TRIPLES      19 PREDICATES      98 URIs      90 LITERALS      5 BLANK NODES

Subject Predicate Object
1 sg:grant.2545608 schema:about anzsrc-for:2208
2 schema:amount N8faaab2977e0417bb5a5e8a87ba36834
3 schema:description DESCRIPTION (provided by applicant): The collection of newly discovered clinically valuable genetic tests is far outpacing our ability to use clinical trials to determine their clinical efficacy and determine which of the collection of tests and associated algorithms are best suited for any given clinical setting. For example, a review of the literature demonstrates that at least 35 published algorithms for the prediction of therapeutic warfarin dosing have been published in the past ten years, nine of which include genotype data (unpublished review). Expenditures to determine the most clinical useful of these algorithms include a total of 19 clinical trials (clinicaltrials.gov, accessed Feb, 2008) Compounding this complexity and adding to the delay of the successful medical use of the rapidly expanding collection of clinically valuable genetic discoveries is the lack of clinical and biomedical informatic methods, tools and infrastructure required to facilitate the successful translation of the discoveries to practical clinical use. Efforts to translate important biomedical informatics methods, tools and processes required to implement important new genetic discoveries in the clinical setting are severely hindered by regulatory, technical and validation barriers not easily resolved in the current clinical-research or clinical enterprise environments. This proposal will test an environment and methodology that creates clinical avatars with data statistically consistent with actual patient electronic medical records. Once created, these clinical avatar medical records will be used to conduct insilico experiments to compare genetic- based algorithms and their predicted value in the clinical setting. We will develop and test the methodology and create the applications by conducting a series of clinical avatar simulations and subsequent analysis of genetic-based warfarin dosing prediction. Once developed, we will conduct a series of insilico clinical trials comparing various clinical and genetic factors to demonstrate the efficacy of the warfarin dosing algorithms. This work is representative of similar projects that may be designed to test other personalized medicine devices such as genetic tests used to quantify risk to cancers, pharmacogenetic problems, and other FDA labeled "IVDMIA" devices (e.g. Genetic Health's Oncotype DX(R)) projected to improve predictive and preventive personalized medicine.
4 schema:endDate 2011-12-30T00:00:00Z
5 schema:funder https://www.grid.ac/institutes/grid.280285.5
6 schema:identifier N0c3c14594ede48f7bd4ee8edd1ca5b53
7 N7967b5250e1f4cd682a45fe95eea201d
8 schema:inLanguage en
9 schema:keywords FeB
10 Genetic Health's Oncotype DX(R
11 IVDMIA
12 METHODS
13 Personali
14 Prediction Models
15 ability
16 actual patient electronic medical records
17 algorithm
18 algorithms
19 applicants
20 application
21 biomedical informatics methods
22 cancer
23 clinical avatar
24 clinical avatar simulations
25 clinical efficacy
26 clinical enterprise environments
27 clinical setting
28 clinical trials
29 collection
30 complexity
31 data
32 delay
33 description
34 device
35 discovery
36 efficacy
37 efforts
38 environment
39 example
40 expenditure
41 genetic factors
42 genetic tests
43 genetic-
44 genetic-based warfarin
45 genetics
46 genotype data
47 given clinical setting
48 important biomedical informatics methods
49 important new genetic discoveries
50 infrastructure
51 insilico clinical trials
52 insilico experiments
53 lack
54 literature
55 medical records
56 methodology
57 other FDA
58 other personalized medicine devices
59 pharmacogenetic problems
60 practical clinical use
61 prediction
62 preventive personalized medicine
63 process
64 proposal
65 representative
66 review
67 risk
68 series
69 similar projects
70 subsequent analysis
71 successful medical use
72 successful translation
73 test
74 therapeutic warfarin
75 tool
76 total
77 unpublished reviews
78 validation barriers
79 valuable genetic discoveries
80 valuable genetic tests
81 values
82 warfarin dosing algorithms
83 work
84 years
85 schema:name Method for Prediction of Efficacy of Genetic-Based Prediction Models of Personali
86 schema:recipient N6e7a70f380c049428b2ac92fe3653238
87 sg:person.01052034706.31
88 https://www.grid.ac/institutes/grid.38142.3c
89 schema:sameAs https://app.dimensions.ai/details/grant/grant.2545608
90 schema:sdDatePublished 2019-03-07T11:59
91 schema:sdLicense https://scigraph.springernature.com/explorer/license/
92 schema:sdPublisher N291180e541134460b56f262cd996c98e
93 schema:startDate 2009-07-01T00:00:00Z
94 schema:url http://projectreporter.nih.gov/project_info_description.cfm?aid=7828231
95 sgo:license sg:explorer/license/
96 sgo:sdDataset grants
97 rdf:type schema:MonetaryGrant
98 N0c3c14594ede48f7bd4ee8edd1ca5b53 schema:name dimensions_id
99 schema:value 2545608
100 rdf:type schema:PropertyValue
101 N291180e541134460b56f262cd996c98e schema:name Springer Nature - SN SciGraph project
102 rdf:type schema:Organization
103 N6e7a70f380c049428b2ac92fe3653238 schema:member sg:person.01052034706.31
104 schema:roleName PI
105 rdf:type schema:Role
106 N7967b5250e1f4cd682a45fe95eea201d schema:name nih_id
107 schema:value R01LM010130
108 rdf:type schema:PropertyValue
109 N8faaab2977e0417bb5a5e8a87ba36834 schema:currency USD
110 schema:value 966964
111 rdf:type schema:MonetaryAmount
112 anzsrc-for:2208 schema:inDefinedTermSet anzsrc-for:
113 rdf:type schema:DefinedTerm
114 sg:person.01052034706.31 schema:affiliation https://www.grid.ac/institutes/grid.38142.3c
115 schema:familyName TONELLATO
116 schema:givenName PETER J.
117 rdf:type schema:Person
118 https://www.grid.ac/institutes/grid.280285.5 schema:Organization
119 https://www.grid.ac/institutes/grid.38142.3c schema:name HARVARD MEDICAL SCHOOL
120 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...